Neuropsychiatric manifestations of Long COVID in India: a persistent problem 2.5 years after disease onset

Anurag Kumar Singh¹Kamlesh Kumar¹MAHAVEER SINGH¹Tushar Jagawat¹Deepak Nathiya¹Balvir Singh Tomar¹Savita Jagawat¹Millenia Jimenez²Melissa Lopez²Janet Miller³Igor Koralnik^2,3*

• ¹NIMS University, Jaipur, India
• ²Northwestern University Feinberg School of Medicine, Chicago, United States
• ³Northwestern Medicine, Chicago, United States

Background Long COVID, also called post-acute sequelae of SARS-CoV-2 infection (PASC)), is a multi-system syndrome affecting millions of people in the world. Neuro-psychiatricworldwide. Neuropsychiatric manifestations of Long COVID are veryparticularly debilitating. However; however, they have not been reported in India in detail from India. Methods This cross-sectional study compared the demographics, comorbidities, symptoms, and neuropsychiatric profiles of patients with Long COVID symptoms lasting more thanthat began within three months of the initial SARS-CoV-2 infection and persisted for approximately 2.5 years at the time of evaluation. The study was conducted at NIMS University (Jaipur, Rajasthan). , India). Results Of 1085 participants, 521 had COVID-19 pneumonia requiring hospitalization, while 564 had a mild initial respiratory presentation and were never hospitalized. AnOn average 2.5 yearyears after acute infection, our principal finding is that Long COVID differs based on COVID-19 initial disease severity. Post-hospitalization patients were older than the non-hospitalized group (43.24 vs. 36.15 yyears; p<0.0001), had a higher body-mass index, and a more frequent prior history of lung disease (7.7% vs. 2.7%; p<0.001). Overall, 69.6% of participants had at least one neurologic symptom, including myalgia (18.5%), dizziness (17.3%), headache (16.6%), pain (15.7%), anosmia (13.3%), brain fog (9.4%), numbness (6.0%), tinnitus (5.5%), and dysgeusia, (3,.7%), with only dizziness being more frequent in the post-hospitalization than the non-hospitalized group (20.3% vs. 14.5%; p=0.012). Conversely, non-hospitalized patients had more frequent fatigue (23.2% vs. 6.0 %; p<0.0001), sleep problems (18.4% vs. 7.7%; p<0.0001), chest pain (8.2% vs. 2.9%; p<0.0001), and GIgastrointestinal symptoms (7.8% vs. 2.9%; p<0.0001)), while post-hospitalization patients more frequently complained of shortness of breath (9.6% vs. 2.7%; p<0.0001). Overall, 4.9% of participants had cognitive dysfunction on the MMSE test, while 10.4% hadsuffered from stress, and 12.7% and 9.2% had anxiety and 9.2% had depression symptoms, respectively, on DASS assessment, without differencesignificant differences between the two groups. Conclusion Our study highlights differences in demographics and clinical presentation of Long COVID between post-hospitalization and non-hospitalized individuals in India. The high frequency of neurologic manifestations 2.5 yyears after disease onset underscores the need for early detection and targeted interventions.